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Zika virus (ZIKV) is a recently emergent flavivirus transmitted by mosquitoes that is medically important 
due to neurological complications in the fetuses of infected mothers in the form of microcephaly, and less 
frequently in adults seen with cases of Guillain-Barré syndrome. ZIKV has a positive-sense RNA genome 
with one open reading frame (ORF) that encodes a single polyprotein. Interestingly, we identified a 550 
base potential ORF marked by characteristics of an internal ribosomal entry site and a Kozak sequence 
on the negative-strand of this positive-sense viral genome that appears to be conserved across all 
well-characterized strains of the virus. To investigate the effect of this potential open reading frame, we 
cloned the ZIKV viral genome with a knock-out mutation to ablate the start codon of the negative strand 
ORF. We determined that the virus was live and viable by infection of C6/36 and Vero cell lines followed 
by immunostaining. RT-PCR was used to amplify the region of the mutation to confirm the presence of 
viral RNA in the supernatant and that the knockout had not reverted. Low and high MOI growth curves 
were conducted with Veros and found that the knockout had greater cytopathic effects with similar rates 
of replication compared to the wildtype H/PF/2013 strain. This is the first ​evidence of a negative-strand 
coding sequence shown to affect the pathogenicity of a positive-sense RNA virus. ​By further exploring the 
role of this coding sequence, and reverse complement ORFs in other ​positive-sense RNA viruses, we can 





Zika Virus (ZIKV) is a recently emergent arbovirus of the Flavivirus genus that infects humans and 
non-human primates. As an arbovirus, it is transmitted by mosquitoes, especially ​Aedes aegypti ​ and ​Ae. 
albopictus​ (CDC, 2019). The virus recently re-emerged in an epidemic from 2015 to 2016 in the Americas 
during which there were 700,000 estimated cases (Ikejezie, et.al., 2017) (​Ozkurt & Tanriverdi, 2017)​. Zika 
is medically important due to complications such as microcephaly, a condition consisting of a smaller than 
normal head circumference in the fetuses of infected mothers, and neurological complications including 
Guillain-Barré Syndrome in infected adults (WHO, 2016). 
 
Flaviviruses have positive-sense RNA genomes that are directly translated into a single open reading 
frame (ORF) encoding all known proteins (​Heinz & Stiasny, 2017)​. The structure of ZIKV has been well 
defined and mapped based on the proteins resulting from this ORF on the positive/coding strand of the 
virus. (Baronti, et.al, 2014). From the single 11kb ORF that is directly translated from the positive strand, 
there are three structural and seven non-structural proteins. The structural proteins include the envelope 
(E), capsid (C), and pre-membrane (prM), and the non-structural are NS1, NS2A, NS2B, NS3, NS4A, 
NS4B and NS5 (​Valente & Moraes, 2019). ​ZIKV also produces a complementary negative-strand RNA 
thought to only serve as a template for the generation of more positive sense RNA copies. However, we 
identified a potential ORF on the negative strand, or noncoding strand (NCS), that appears to be 
conserved between many well-characterized strains of ZIKV. The start codon of the potential 
negative-strand ORF exists within a Kozak sequence and is marked by a possible secondary and tertiary 
RNA structure just upstream of the sequence that we predicted may function as an internal ribosome 
entry site (IRES) element to enable translation.  
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To investigate whether this sequence affects the pathogenesis of ZIKV, we knocked out the start codon of 
the negative-strand ORF using a g-block with a single nucleotide change that maintains the amino acid 
sequence of the positive-strand. We produced the cDNA genome with this mutation, transcribed the 
genome into a full-length RNA, and transfected C6/36 mosquito cells to passage the mutated virus. The 
C6/36 cell line is an established cell line known to transmit Zika (Walker, et al., 2014) (Widman, et al., 
2017). We verified live virus by immunostaining and used RT-PCR and sequencing to verify that the 
mutation did not revert after several subsequent passages. We then infected C6/36 cells and CCL-81 
Veros to test the cytopathic effects (CPE) of the mutant compared to the wildtype virus. We used the 
CCL-81 Vero cell line because it is known to show CPE when infected with wildtype Zika (Moser, et al., 
2018) (​Willard, et. al., 2017)​. We then infected Veros at low and high multiplicities of infection (MOI) to 
determine what role the negative-strand ORF plays in the viral replication and spread. We found that the 
knockout negative-strand ORF mutant has greater cytopathic effects in Veros compared to wildtype virus, 




ZIKV sequence analysis 
 
The sequences of the potential negative strand open reading frame from multiple strains of ZIKV were 
aligned using Geneious to search for consensus in the start codon region. Zika virus strains analyzed 
include MR766 (Uganda, 1947, GenBank: MK105975.1), PRVABC59 (Puerto Rico, 2015, GenBank: 
MK713748.1), Dakar 41525 (GenBank: MG758786.1), ZikaSPH2015 (Brazil, 2015, GenBank: 
KU321639.1), FSS13025 (Cambodia, 2010, GenBank: MH158236.1), BeH819015 (Brazil, 2015, 
GenBank: KU365778.1), and H/PF/2013 (French Polynesia, GenBank: KJ776791.2). 
 
Production of full-length RNA with negative-strand ORF knockout 
 
The 2013 French Polynesia Zika virus cDNA (H/PF/2013 infectious clone) was stored at -20°C in 4 DNA 
fragments--A, B, C, and D--each in pUC57 to be transformed into competent ​E. coli ​ cells for multiplication. 
The fragment-vectors were transformed following the New England Biolabs (NEB) transformation 
protocol, except the transformation was plated and incubated at 30 °C instead of 37 °C to decrease the 
chance of mutation. Colonies were also grown at 30 °C and incubated for 15 to 20 hours. The cultures 
were screened by digesting and verifying length of fragment with gel electrophoresis.  
 
The start codon of the negative-strand open reading frame (ORF) is located within the C fragment. To 
knock-out the start codon, a 300 base g-block from Integrated DNA Technologies (IDT) was designed to 
include a single nucleotide mutation that did not affect the protein sequence of the positive-strand and 
included restriction sites BstXI and EcoNI to enable insertion. The g-block was ligated into the C 
fragment-vector with New England Biolabs (NEB) T4 DNA ligase. The mutated C fragment was 
transformed, cultured, and screened as previously described.  
 
The mutant C fragment was then sequenced with reactions containing 8 pmol of primer and 
approximately 200 ng of the fragment in 12 µl of water.The sequence results were produced by Eurofins 
Genomics and analyzed using Geneious Prime and compared to the wild-type sequence to verify that the 
mutation was present in the clone selected and that there were no other mutations present.  
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The four fragments, A, B, C (mutant), and D, were digested with EcoRI-HF, Bsu36I, BstXI, SfiI, and SmaI 
and purified by gel electrophoresis and gel extraction (Fig. 1C). The fragments were then ligated together 
with NEB T4 DNA ligase kit. The product length was verified by gel electrophoresis as approximately 11 
kb, the length of the full-length genome. The full-length RNA was transcribed from the cDNA using the 
NEB T7 RNA polymerase kit. A T7 RNA polymerase promoter was included upstream of the 5’ UTR in the 
A fragment to enable ​in vitro ​ transcription (Fig. 2). 
 
Figure 1. Design of the negative strand ORF knockout​. (A) Schematic of the ZIKV genome positive-strand including all known 
proteins of the virus. (B) Location of the potential open reading frame of interest on the negative strand of the virus. (C) Schematic of 
the infectious clone including restriction sites used to ligate the fragments. (D) Chromatogram of the negative-strand showing where 




Figure 2. Production of live Zika virus.​  A flowchart outlining the main steps of making the virus. Including cloning, digesting, and 
ligating the fragments with T4 DNA ligase (NEB) resulting in cDNA. Then transcribing the cDNA using T7 RNA polymerase 
(Invitrogen) and electroporating with C6/36 cells, followed by incubation. Made in-part with biorender.com  
 
Transfecting C6/36 cells 
 
Mosquito cells (C6/36 cell line) were transfected with the RNA genome via electroporation (Fig. 2). Prior 
to electroporation, the cells were rinsed 3 times with DPBS by centrifugation and resuspension. The final 
resuspension resulted in an approximate concentration of 8*10 ​6 ​ cells per 800 µl based on the confluency 
of the flasks used. Then, 740 µl of the resuspended cells and 60 µl of the T7 reaction were added to a 4 
mm gap cuvette. The negative control (NC) was 740 µl of the cell mixture and 60 µl DPBS. The mixture 
was pulsed 3 times at 450 V, ∞ Ω, and 25 µF and then rested at room temperature for 10 minutes to 
recover. The cells incubated at 32.0 °C and 5.0 % CO​2 ​. The virus was passaged twice by removing the 
media, centrifugation to purify, and inoculating 50% confluent T75 with 2 mls of day 5 supernatant and 10 
mls of fresh C6/36 media.  
 
C6/36 cells were used because the cell line is known to replicate the virus with little to no cell death, 
making it a suitable line for passaging the virus (Moser, et al., 2018). The C6/36 cells were cultured in 
media consisting of Minimum Essential Media (MEM) with 6.5% Fetal Bovine Serum (FBS), 1% anti-anti 
(1000x), and 1% non-essential amino acids. 
 
Verifying Live Virus 
 
Immunostaining was used to test for the presence of viral proteins in the passaged cells. The supernatant 
was removed from the infected and negative control flasks and then the T75 flasks were fixed with 
methanol/acetone (50:50) for at least 30 minutes at 4 °C. The flasks were then blocked with 5% non-fat 
milk/DPBS (blocking buffer) at room temp before incubating at 37 °C primary antibodies 4G2 and 2H2 
diluted 1:1000 in the blocking buffer. The flasks were washed, then incubated with secondary antibody, 
horseradish-peroxidase (HRP)-conjugated goat-anti-mouse IgG (KPL), diluted 6.6:10000 in blocking 
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buffer. The flasks were washed again then TrueBlue peroxidase substrate (KPL) was used for signal 
detection.  
 
The culture medium was clarified to create virus stocks from the infected and negative control flasks by 
centrifuging the medium at 1500rpm for 10 minutes to purify the medium from cells and cell particles. The 
stocks were then stored at -80 °C in single-use 1 ml aliquots. Viral RNA was extracted from the clarified 
stock of the second passage (p2) using the QIAamp Viral RNA Mini Kit (Qiagen). The viral RNA was then 
reverse-transcribed using Superscript IV (Thermo Fisher Scientific) with the primers in Table 1. A region 
containing the mutation (316 bp) was PCR amplified and visualized via gel electrophoresis to verify the 
presence of viral RNA in the infected flasks. The PCR product was then sequenced by methods 
previously described to verify that the negative-strand ORF knockout mutation was still present and had 
not reverted to wild-type ZIKV. 
 
Table 1. RT-PCR primers to verify live virus and mutation 
 
 
Production of viral stocks 
 
To make a Vero stock of the mutant virus, CCL-81 Veros were infected by inoculation with the mutant 
viral stock from C6/36 p2. A 95% confluent CCL-81 T75 was rinsed with DPBS then inoculated with 500 
µl of the C6/36 µp2 stock and 2ml DPBS. A NC flask was also inoculated with the supernatant from the 
C6/36 p2 NC using the same protocol. The flask was incubated at 37.0 °C and 5.0% CO​2 ​ and rocked 
every 15 minutes for 75 minutes. Then 10 ml of Vero media was added to the flasks and they were 
returned to the same incubator. The supernatant was centrifuged for 10 minutes at 1500rpm to purify the 
stock before aliquoting and stored at -80 °C. The Veros were cultured in Dulbecco’s modified Eagle’s 
medium (DMEM) with 10% fetal clone II and 1% anti-anti. 
 
Cytopathic effects in Veros and C6/36 cells 
 
The cytopathic effects of the negative-strand ORF knockout were compared to wild-type ZIKV, a 12-well 
plate was seeded with 2x10 ​5 ​ cells/well of CCL-81s and another 12-well plate was seeded with 5x10 ​5 
cells/well C6/36s. The next day, cells were inoculated with 4 different dilutions of the wild-type or mutant 
virus, and 4 wells in each were used as a NC. Dilutions were done by a factor of 10 in order to increase 
the probability of having wells for each virus that showed the cytopathic effects without killing all of the 
cells. The wells were then imaged on days 1, 2, and 4 at which point they were fixed and stained 
according to the previous immunostaining protocol. After a day of drying, the cells were imaged again with 




The viral stocks were titrated on CCL-81 Vero cells in duplicate and replicated for accurate calculation of 
multiplicity of infection (MOI). CCL-81 Vero cells were seeded in a 6-well plate at 2x10^5 cells/mL in 3 mL 
of media and incubated for at least 24 hours. Cells were infected at an MOI of 1 or 0.01 in triplicate. 
Supernatant was collected at 4, 12, 24, 48, and 72 hours post infection and preserved at -80 °C. The 
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samples were titrated on CCL-81s and viral foci were observed after 42 hours of incubation. The plates 
were fixed with 4% paraformaldehyde and immunostained with 4G2 and 2H2 primary antibodies, 
horseradish-peroxidase (HRP)-conjugated goat-anti-mouse secondary antibody (Sigma), then TrueBlue 





Conserved Sequence and Identity to Kozak Rule 
 
The strain we used to represent wild type Zika virus is the 2013 French Polynesia human isolate strain 
H/PF/2013. This strain has been well characterized and been previously sequenced to verify that the 
sequence exactly aligned with the published sequence (accession number KJ776791.2) (Widman, et. al. 
2017). In order to assess how well this strain represents the features of the potential negative-strand open 
reading frame, we aligned the sequences of 7 popular strains of the virus (accession numbers 
MK105975.1, MK713748.1, MG758786.1, KU321639.1, MH158236.1, KU365778.1, KJ776791.2) and 
found that the region directly surrounding the start codon was conserved and aligned with the canonical 
Kozak sequence (Fig. 3). The conserved nature of this sequence and its identity to the Kozak Rule 
suggest that this start codon on the negative strand may have a functional role in the virus’ pathogenicity.  
 
 
Figure 3. Alignment of multiple ZIKV strains with the canonical Kozak sequence.​ Strain, Accession number, and the region 
including the start codon of the potential negative-strand ORF. 
 
Verification of Live Virus and the Conserved Mutation  
 
We predict that the ORF may be translated due to the conservation of the start region and identity to the 
Kozak rule, in addition to the predicted RNA structure of the upstream region that may function as an 
internal ribosome entry site (IRES) for in vivo translation. Here, we knocked out the start codon, while 
maintaining the amino acid sequence of the positive strand ORF, a synonymous mutation. In order to 
assess whether the knockout was able to infect and propagate in the C6/36 cell line, we extracted RNA 
from the supernatant and did RT-PCR to verify the presence of live virus after two passages (Fig. 4A). 
The primers were designed to amplify a 300 base region containing the knockout mutation. We then 
sequenced the region via Eurofins Genomics to determine whether the mutation was maintained or 
reverted (Fig. 4B). Together, these results demonstrate that the virus is still viable and able to replicate 




Figure 4. Recovery of live virus.​ (A) RT-PCR product of viral cDNA from C6/36 and amplification of mutated region. (B) The 
chromatogram of the PCR product highlighting the mutated base in the reverse complement of the positive strand (G to T).  
 
𝚫-NS ORF and Wild-type Virus Cause Similar Cytopathic Effects in CCL-81 and C6/36 Cell Lines  
 
The viral stocks of the knockout virus, Δ-NS ORF, and wildtype, H/PF/2013, were produced using C6/36 
cells. We evaluated the capacity of both viruses to cause cytopathic effects (CPE) in both CCL-81 Vero 
cells (Fig. 5) and C6/36 cells (Fig. 6). The wildtype strain is known to cause CPE in Veros, but does not 
cause CPE in C6/36 mosquito cells. CPE is observable in figure 5 by the increased reflection of white 
light off the affected cells as seen on day 4, 96-hours post infection (hpi) on the Vero cells infected with 
Δ-NS ORF and wildtype. Viral presence in Veros on day 4 was also confirmed with TrueBlue 
immunostaining (Fig. 5). The infection of C6/36 cells did not show visible CPE, but the presence of live 
virus was confirmed by immunostaining (Fig. 6). In sum, these results demonstrate that the mutant and 




Figure 5. CCL-81 Veros imaging the cytopathic effects of the mutant and wild-type ZIKV.​ Cytopathic effects were visualized 
with 40x magnification on an inverted microscope. Images taken 24, 48, 96 hours post infection (hpi) and stained on day 4 with 




Figure 6. C6/36 comparing the effect of the mutant and wild-type virus. ​Cells visualized with 40x magnification on an inverted 




Cytopathic Effects and Growth curves at MOIs of 1 and 0.01  
 
We demonstrated that both the Δ-NS ORF mutant and the wildtype virus cause cytopathic effects in 
CCL-81 Veros, but we do not know how the cytopathic effects compare at specific multiplicities of 
infection (MOIs). We hypothesize that due to the 10-fold difference in inoculum concentration required to 
visualize similar results, that there may be a difference in phenotype when the inoculum concentrations 
are equivalent. To assess this, the viral stocks were titrated and Veros were infected at an MOI of 1 and 
0.01. Growth curves were produced from the titers of the supernatant at 4, 12, 24, 48, and 72-hours post 
infection (hpi) to determine if the cytopathic effects correlate with differences in viral concentrations or 
rates of replication and spread. Upon infection at an MOI of 1,  Δ-NS ORF showed greater CPE that the 
wildtype strain visualized at 48 hpi. Significant variance in CPE was visualized at 72 hpi when the cells 
infected by the mutant had undergone apoptosis and were suspended in the supernatant with no cells in 
a monolayer on the flask. The Veros infected with wildtype virus also showed increased CPE but still 
maintained a monolayer (Fig. 7A). The growth curve verifies the inoculum concentration, and that the viral 
concentrations at each time point and the rates of replication are comparable between the mutant and 
wildtype (Fig. 7B).  
 
When infected at an MOI of 0.01, the Δ-NS ORF still showed greater CPE than wildtype and was 
visualized at 72 hpi. The mutant caused more Vero cells to be suspended in the supernatant than in the 
wildtype infected wells (Fig. 8A). The growth curve verifies the correct inoculum concentration, and that 
there is not a significant difference in viral concentration or rate of growth that correlates with the 
differences in CPE (Fig. 8B). 
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Figure 7. Growth curve on CCL-81 Veros at an MOI of 1. ​(A) Cells visualized with 10x magnification on an inverted microscope. 






Figure 8. Growth curve on CCL-81 Veros at an MOI of 0.01. ​(A) Cells visualized with 10x magnification on an inverted 
microscope. Images taken 4, 24, 48, and 72 hpi (B) Growth Curve of inoculum and supernatant collected at 4, 12, 24, 48, and 72 hpi 




Though the proteins translated from the single positive-strand open reading frame have been well 
characterized, the potential influence of a negative-strand open reading frame has yet to be explored 
(Baronti, et.al, 2014). The negative-strand ORF appeared to have an important role in the function of Zika 
virus due to the conservation of this ORF between strains, adherence to the Kozak rule, and potential for 
an internal ribosome entry site (IRES) upstream of the start codon. After knocking out the start codon, the 
virus was still able to infect and replicate without reverting the mutation, suggesting that the 
negative-strand ORF is not necessary for viral replication and infection to occur in vitro. Infection of the 
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C6/36 cell line and the CCL-81 Vero cell line showed that the mutation did not change the ability of the 
virus to cause cytopathic effects (CPE) in Veros nor did the mutation enable CPE to be observed in C6/36 
cells. The growth curve data suggests, however, that when controlling for the multiplicity of infection the 
mutant caused more apoptosis without a significant difference in the viral concentrations (Fig. 7 and 8).  
 
The MOI of 1 growth curve (Figure 7B) reveals that the mutation does not affect the ability of the virus to 
infect the cell since the wild-type virus and the knockout maintain similar viral concentrations and rates of 
growth. The same pattern is observed in the MOI of 0.01 growth curve (Figure 8B) suggesting that the 
mutation doesn’t inhibit basic viral replication or speed of the viral life cycle. The images taken throughout 
the growth curve show that the Vero cells infected with the mutant entered apoptosis faster than wildtype. 
This trend suggests that the Δ-NS ORF mutant is more easily identifiable by the host's innate immune 
system. Due to limitations in the immune response of Vero cells, the interaction of this mutant with a host 
innate immune system can be better assessed in a mouse model and cell lines that have more viral 
sensing pathways than CCL-81 Veros. Testing the effects of the virus by infecting a mouse model would 
also provide a better understanding of any differences in viability and pathogenicity that could be seen in 
humans (Gorman, et al., 2018). 
 
The role of the negative-strand ORF can also be determined by evaluating whether the ORF is translated 
into a protein. This can be assessed by using an expression vector such as pVR21 to cause a mouse to 
produce antibodies specific to this potential protein. Due to the location of this ORF on the negative 
strand, it may be necessary to utilize deep proteomics to determine if the protein is translated in any 
capacity. We will also further investigate the region upstream of the start codon to determine if the 
secondary RNA structure functions as an IRES by inserting the region into circular GFP and dual 
luciferase reporters to assess if the IRES is capable of inducing translation. 
 
A negative-strand protein has never been discovered in any positive-sense RNA virus, which is a defining 
feature of the pathogen group. However, another recent study reported potential coding capacity of the 
negative-strand ORF of various positive-sense RNA viruses including three mosquito associated 
narnaviruses (Dinan, et. al., 2020). Scientists have predicted during this recent discovery that there are 
likely more ambigrammatic viruses to be discovered (DeRisi, et. al. 2019). Our discovery of a difference in 
phenotype due to knocking out a negative-strand ORF in Zika virus reveals this as the first 
negative-strand coding sequence shown to affect the pathogenicity of a positive-sense RNA virus. This 
finding also supports the possibility that other positive-sense RNA viruses could have negative-strand 
coding sequences that play a role in viral function.  
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